UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

BMC cancer, 2007-01, Vol.7 (1), p.2-2, Article 2

2007

Volltextzugriff (PDF)

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (19), p.8809-8817

2005

Volltextzugriff (PDF)

Methods and goals for the use of in vitro and in vivo chemosensitivity testing

Molecular biotechnology, 2007-02, Vol.35 (2), p.185-197

2007

Volltextzugriff (PDF)

Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

PPAR Research, 2008-01, Vol.2008 (2008), p.692-698-062

2008

Volltextzugriff (PDF)

Altered tumor vessel maturation and proliferation in placenta growth factor‐producing tumors: Potential relationship to post‐therapy tumor angiogenesis and recurrence

International journal of cancer, 2003-06, Vol.105 (2), p.158-164

2003

Volltextzugriff (PDF)

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

Cancer Immunology, Immunotherapy, 2005-04, Vol.54 (4), p.315-327

2005

Volltextzugriff (PDF)

Chronotherapy and Chronotoxicity of the Cyclooxygenase-2 Inhibitor, Celecoxib, in Athymic Mice Bearing Human Breast Cancer Xenografts

Clinical cancer research, 2001-10, Vol.7 (10), p.3178-3185

2001

Volltextzugriff (PDF)

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (7), p.2029-2033

2002

Volltextzugriff (PDF)

Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments

Clinical cancer research, 2000-12, Vol.6 (12), p.4900-4907

2000

Volltextzugriff (PDF)

Advantage of Combining NLCQ-1 (NSC 709257) with Radiation in Treatment of Human Head and Neck Xenografts

Radiation research, 2007-07, Vol.168 (1), p.65-71

2007

Volltextzugriff (PDF)

Tumor-specific Regulation of Angiogenic Growth Factors and Their Receptors during Recovery from Cytotoxic Therapy

Clinical cancer research, 2002-04, Vol.8 (4), p.1213-1222

2002

Volltextzugriff (PDF)

Modulation of Marrow Proliferation and Chemosensitivity by Tumor-produced Cytokines from Syngeneic Pancreatic Tumor Lines

Clinical cancer research, 2002-05, Vol.8 (5), p.1301-1309

2002

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor-γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines

Anti-cancer drugs, 2007-06, Vol.18 (5), p.525-534

2007

Volltextzugriff (PDF)

Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients

The Journal of nuclear medicine (1978), 2003-01, Vol.44 (1), p.67-76

2003

Volltextzugriff (PDF)

Degranulating Eosinophils in Human Endometriosis

The American journal of pathology, 2000-05, Vol.156 (5), p.1581-1588

2000

Volltextzugriff (PDF)

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

Cancer research (Chicago, Ill.), 1995-09, Vol.55 (17), p.3825-3834

1995

Volltextzugriff (PDF)

An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: Effects of p53 expression

International journal of cancer, 2004-01, Vol.108 (2), p.293-300

2004

Volltextzugriff (PDF)

Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium

Fertility and sterility, 2002-12, Vol.78 (6), p.1294-1300

2002

Volltextzugriff (PDF)

Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy : Doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type

Cancer research (Chicago, Ill.), 1997-12, Vol.57 (23), p.5309-5319

1997

Volltextzugriff (PDF)

Radioimmunotherapy of Small Volume Disease of Colorectal Cancer Metastatic to the Liver: Preclinical Evaluation in Comparison to Standard Chemotherapy and Initial Results of a Phase I Clinical Study

Clinical cancer research, 1999-10, Vol.5 (10), p.3232s

1999

Volltextzugriff (PDF)

Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia

International journal of cancer, 2001-11, Vol.94 (4), p.564-571

2001

Volltextzugriff (PDF)

Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft Model

Bioconjugate chemistry, 1997-07, Vol.8 (4), p.595-604

1997

Volltextzugriff (PDF)

Selection of radioimmunoconjugates for the therapy of well‐established or micrometastatic colon carcinoma

International journal of cancer, 1997-07, Vol.72 (3), p.477-485

1997

Volltextzugriff (PDF)

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Cancer Immunology, Immunotherapy, 1997-05, Vol.44 (3), p.179-188

1997

Volltextzugriff (PDF)

Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts

Cancer research (Chicago, Ill.), 1994, Vol.54 (1), p.142-151

1994

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(45)
Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Medical Sciences
(43)
Animals
(42)
Humans
(42)
Oncology
(38)
Female
(36)
Mice
(36)
Mice, Nude
(29)
Tumors
(25)
Radioimmunotherapy
(23)
Neoplasm Transplantation
(18)
Pharmacology. Drug Treatments
(18)
Transplantation, Heterologous
(18)
Treatment. General Aspects
(18)
Carcinoembryonic Antigen - Immunology
(17)
Radiation Therapy And Radiosensitizing Agent
(17)
Treatment With Physical Agents
(17)
Tumor Cells, Cultured
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)

Methods and goals for the use of in vitro and in vivo chemosensitivity testing

Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

Altered tumor vessel maturation and proliferation in placenta growth factor‐producing tumors: Potential relationship to post‐therapy tumor angiogenesis and recurrence

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

Chronotherapy and Chronotoxicity of the Cyclooxygenase-2 Inhibitor, Celecoxib, in Athymic Mice Bearing Human Breast Cancer Xenografts

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments

Advantage of Combining NLCQ-1 (NSC 709257) with Radiation in Treatment of Human Head and Neck Xenografts

Tumor-specific Regulation of Angiogenic Growth Factors and Their Receptors during Recovery from Cytotoxic Therapy

Modulation of Marrow Proliferation and Chemosensitivity by Tumor-produced Cytokines from Syngeneic Pancreatic Tumor Lines

Peroxisome proliferator-activated receptor-γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines

Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients

Degranulating Eosinophils in Human Endometriosis

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: Effects of p53 expression

Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium

Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy : Doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type

Radioimmunotherapy of Small Volume Disease of Colorectal Cancer Metastatic to the Liver: Preclinical Evaluation in Comparison to Standard Chemotherapy and Initial Results of a Phase I Clinical Study

Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia

Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft Model

Selection of radioimmunoconjugates for the therapy of well‐established or micrometastatic colon carcinoma

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts

Aktive Filter

Suchergebnisse filtern